Skip to main content

Table 1 Characteristics of the study population according to dextrose administration

From: The administration of dextrose during in-hospital cardiac arrest is associated with increased mortality and neurologic morbidity

Characteristic Received dextrose during cardiac arrest P value
No Yes
(n = 95,856) (n = 4,173)
Demographics    
Age in years, median (IQR) 69 (57–79) 65 (53–77) <0.001
Sex, number (percentage)    0.03
Female 40,306 (42.1) 1,690 (40.3)  
Male 55,550 (58.0) 2,499 (59.7)  
Race, number (percentage)    <0.001
White 68,474 (76.8) 2,527 (64.8)  
Black 17,109 (19.2) 1,208 (31.0)  
Other 3,551 (4.0) 165 (4.2)  
Type of admission, number (percentage)    <0.001
Medical-Non-cardiac 41,798 (43.6) 2,267 (54.3)  
Medical-Cardiac 32,031 (35.4) 1,212 (29.1)  
Surgical-Non-cardiac 10,877 (11.4) 421 (10.1)  
Surgical-Cardiac 6,188 (6.5) 185 (4.4)  
Trauma 2,777 (2.9) 73 (1.8)  
Other 272 (0.3) 14 (0.3)  
Pre-existing conditions, number (percentage)    
Cardiac    
Arrhythmia 31,414 (32.9) 1,188 (28.5) <0.001
History of MI 15,864 (16.6) 584 (14.0) <0.001
MI this admission 17,148 (17.9) 472 (11.3) <0.001
History of heart failure 20,090 (21.0) 911 (21.9) 0.19
Heart failure this admission 17,091 (17.9) 702 (16.8) 0.08
Non-cardiac    
Respiratory insufficiency 40,001 (41.9) 1,672 (40.2) 0.03
Diabetes mellitus 28,759 (30.1) 1,717 (41.2) <0.001
Renal insufficiency 30,784 (32.2) 1,838 (44.0) <0.001
Metastatic/Hematologic malignancy 11,801 (12.4) 471 (11.3) 0.05
Hypotension/Hypoperfusion 26,263 (27.5) 1,107 (26.6) 0.21
Pneumonia 13,015 (13.6) 592 (14.2) 0.30
Baseline depression in CNS function 12,273 (12.8) 564 (13.5) 0.18
Metabolic/Electrolyte abnormality 15,477 (16.2) 974 (23.3) <0.001
Septicemia 14,586 (15.3) 872 (20.9) <0.001
Acute CNS non-stroke event 6,991 (7.3) 314 (7.5) 0.58
Hepatic insufficiency 6,724 (7.0) 431 (10.4) <0.001
Acute stroke 3,686 (3.9) 144 (3.5) 0.18
Major trauma 3,587 (3.8) 104 (2.5) <0.001
  1. CNS, central nervous system; IQR, interquartile range; MI, myocardial infarction.